Insomnia Drug Shows Promise

(MedPage Today) -- Daridorexant, an investigational dual orexin receptor antagonist (DORA), met its primary endpoints in treating insomnia, data from the first of two phase III randomized placebo-controlled trials showed.
Compared with placebo...